- |||||||||| Enrollment change, Trial termination: Videogame-based Incentives for Smoking Cessation (clinicaltrials.gov) - Apr 26, 2019
P=N/A, N=24, Terminated, Phase classification: P1/2 --> P=N/A N=100 --> 24 | Active, not recruiting --> Terminated; There were a number of bugs in the game that meant the participants were not getting the intended intervention.
- |||||||||| Trial completion, Enrollment change: System Based Tracking and Treatment for Emergency Patients Who Smoke: STTEPS (clinicaltrials.gov) - Apr 25, 2019
P=N/A, N=444, Completed, N=100 --> 24 | Active, not recruiting --> Terminated; There were a number of bugs in the game that meant the participants were not getting the intended intervention. Recruiting --> Completed | N=692 --> 444
- |||||||||| Trial completion: Contingency Management for Smoking in Substance Abusers (clinicaltrials.gov) - Jan 23, 2019
P=N/A, N=340, Completed, Recruiting --> Completed | Trial completion date: Mar 2018 --> Jul 2018 | Trial primary completion date: Mar 2018 --> Jul 2018 Recruiting --> Completed
- |||||||||| Trial completion, Trial completion date, Trial primary completion date: Smoking Cessation Intervention in Public Housing (clinicaltrials.gov) - Dec 13, 2018
P=N/A, N=420, Completed, N=30 --> 42 | Recruiting --> Terminated; Insufficient enrollment Enrolling by invitation --> Completed | Trial completion date: Dec 2013 --> May 2018 | Trial primary completion date: Mar 2013 --> May 2018
- |||||||||| Trial completion: Web and Mobile Smoking Cessation (clinicaltrials.gov) - Dec 13, 2018
P=N/A, N=1266, Completed, Enrolling by invitation --> Completed | Trial completion date: Dec 2013 --> May 2018 | Trial primary completion date: Mar 2013 --> May 2018 Active, not recruiting --> Completed
- |||||||||| Chantix (varenicline) / Pfizer
Trial completion, Trial completion date, Trial primary completion date: Tobacco Intervention in Buprenorphine Treatment (clinicaltrials.gov) - Nov 13, 2018 P3, N=175, Completed, Recruiting --> Completed | Phase classification: P1 --> PN/A Active, not recruiting --> Completed | Trial completion date: Apr 2015 --> Dec 2016 | Trial primary completion date: Mar 2015 --> Apr 2016
- |||||||||| bupropion sustained-release / Generic mfg.
Trial completion, Phase classification, Enrollment change: Combined Pharmaco/Behavior Therapy in Adolescent Smokers (clinicaltrials.gov) - Oct 3, 2018 P2, N=134, Completed, Not yet recruiting --> Completed | N=546 --> 722 Recruiting --> Completed | Phase classification: PN/A --> P2 | N=216 --> 134
- |||||||||| Trial completion: Nicotine Metabolism and Low Nicotine Cigarettes (clinicaltrials.gov) - Jul 19, 2018
P=N/A, N=207, Completed, N=40 --> 22 | Recruiting --> Terminated; left institution protocol closed Active, not recruiting --> Completed
- |||||||||| Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Decision Support for Smoking Cessation in Young Adults With Severe Mental Illness (clinicaltrials.gov) - Jun 27, 2018
P=N/A, N=58, Completed, Active, not recruiting --> Completed | N=400 --> 280 | Trial completion date: Oct 2018 --> Feb 2018 Active, not recruiting --> Completed | N=110 --> 58 | Trial completion date: Dec 2015 --> Feb 2018 | Trial primary completion date: Apr 2015 --> Feb 2018
- |||||||||| Chantix (varenicline) / Pfizer
Trial completion, Phase classification, Enrollment change: Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity (clinicaltrials.gov) - Jun 3, 2018 P2, N=140, Completed, Active, not recruiting --> Completed | Phase classification: P4 --> PN/A Recruiting --> Completed | Phase classification: P4 --> P2 | N=214 --> 140
- |||||||||| Trial completion, Trial completion date, Trial primary completion date: A Trial of Positively Smoke Free Group Therapy for HIV-infected Smokers (clinicaltrials.gov) - Apr 27, 2018
P=N/A, N=449, Completed, Recruiting --> Completed Not yet recruiting --> Completed | Trial completion date: Aug 2018 --> Mar 2018 | Trial primary completion date: Aug 2017 --> Mar 2018
- |||||||||| Phase classification, Enrollment change: Brain Circuits in Schizophrenia and Smoking (clinicaltrials.gov) - Apr 6, 2018
P, N=42, Completed, Active, not recruiting --> Completed | Phase classification: PN/A --> P | N=100 --> 177 Phase classification: P=N/A --> P | N=300 --> 42
- |||||||||| galantamine extended release / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date: Effect of Galantamine on Short-term Abstinence (clinicaltrials.gov) - Apr 6, 2018 P2, N=98, Completed, Active, not recruiting --> Completed Recruiting --> Completed | Trial completion date: Mar 2018 --> Nov 2017 | Trial primary completion date: Feb 2018 --> Nov 2017
- |||||||||| FluMist (influenza vaccine, live, intranasal) / AstraZeneca, FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Trial completion, Phase classification, Enrollment change: Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers (clinicaltrials.gov) - Apr 4, 2018 P, N=62, Completed, Phase classification: P=N/A --> P Recruiting --> Completed | Phase classification: PN/A --> P | N=100 --> 62
|